Independent life sciences advisory

Scientific depth.
Commercial clarity.

Evidence-led decisions for biotech investors, pharma teams and digital health companies.

What I do

Four ways to work together.

01

Scientific & Clinical Due Diligence

Evidence, differentiation and risks before an investment or licensing decision.

02

Portfolio & Competitive Strategy

Prioritize assets, indications and opportunities with a clear decision framework.

03

Evidence & Digital Health Advisory

Translate real-world evidence and patient insights into commercial decisions.

04

BD Advisory & Fractional BD Lead

Business development strategy, partner outreach and hands-on deal execution support.

Professional experience

Organizations I have worked with

BCG Digital Ventures
Sartorius
Nuvisan
Orbion
AstraZeneca
Incyte Biosciences
Lundbeck
MSD / Merck & Co.
Sanofi
AbbVie
Daiichi Sankyo
Eli Lilly
Novo Nordisk
Bayer
Scitaris
Temedica

Recommendations

What others say about my work

“I can confidently say he is one of the most dedicated and skilled consultants I’ve worked with. Dennis has a strong scientific mindset, and his analytical skills are exceptional; he has a knack for digging deep into data and uncovering insights that others might miss.”

Jonas Hanske

Former Scitaris project manager · Director, Corporate Development & Strategy, BioNTech SE

1 of 3

Selected work

Evidence you can act on.

View case studies